Glucose variability in PD-1 inhibitors-induced diabetes mellitus

Affiliations

¹ Division of Endocrinology, Diabetes and Metabolism, Santa Croce and Carle Hospital, Cuneo, Italy. francesco.tassone@gmail.com.
² Division of Endocrinology, Diabetes and Metabolism, Santa Croce and Carle Hospital, Cuneo, Italy.

Comment

Francesco Tassone et al. Acta Diabetol. 2019 Mar.

. 2019 Mar;56(3):379-380.

doi: 10.1007/s00592-018-1263-3. Epub 2018 Dec 1.

¹ Division of Endocrinology, Diabetes and Metabolism, Santa Croce and Carle Hospital, Cuneo, Italy. francesco.tassone@gmail.com.
² Division of Endocrinology, Diabetes and Metabolism, Santa Croce and Carle Hospital, Cuneo, Italy.

No abstract available

Comment on

Diabetes mellitus induced by PD-1 and PD-L1 inhibitors: description of pancreatic endocrine and exocrine phenotype.
Marchand L, Thivolet A, Dalle S, Chikh K, Reffet S, Vouillarmet J, Fabien N, Cugnet-Anceau C, Thivolet C. Marchand L, et al. Acta Diabetol. 2019 Apr;56(4):441-448. doi: 10.1007/s00592-018-1234-8. Epub 2018 Oct 4. Acta Diabetol. 2019. PMID: 30284618
Nivolumab-induced fulminant type 1 diabetes (T1D): the first Italian case report with long follow-up and flash glucose monitoring.
Tassone F, Colantonio I, Gamarra E, Gianotti L, Baffoni C, Magro G, Borretta G. Tassone F, et al. Acta Diabetol. 2019 Apr;56(4):489-490. doi: 10.1007/s00592-018-1246-4. Epub 2018 Oct 25. Acta Diabetol. 2019. PMID: 30361845 No abstract available.